Back to Search

ROBERTA HITT, PH.D.

PH.D.

Clinical Psychologist

NPI: 1043547821IndividualAccepts Medicare

Specialties, Licenses & Credentials

Group Psychotherapy Psychologist

Psychologist — Group Psychotherapy

Code: 103TP2701X

6301013105(MI)
Clinical PsychologistPrimary

Psychologist — Clinical

Code: 103TC0700X

6301013105(MI)

CMS Specialties

PrimaryCLINICAL PSYCHOLOGIST

Education

OTHER

Class of 2005

Research & Publications (20)

DER7, encoding alpha-glucosidase I is essential for degradation of malfolded glycoproteins of the endoplasmic reticulum.
PMID 15450188·FEMS Yeast Res·2004
8-other
Der1p, a protein required for degradation of malfolded soluble proteins of the endoplasmic reticulum: topology and Der1-like proteins.
PMID 15093775·FEMS Yeast Res·2004
4-observational
Pre-treatment serum lactate dehydrogenase level is an important prognostic factor in high-grade extremity osteosarcoma.
PMID 19574207·Clin Transl Oncol·2009
8-other
Regulation of IL2 and NUCB1 in mononuclear cells treated with acyl glucuronide of mycophenolic acid reveals effects independent of inosine monophosphate dehydrogenase inhibition.
PMID 19065122·Ther Drug Monit·2009
8-other
Platinum-based chemotherapy plus cetuximab in head and neck cancer.
PMID 18784101·N Engl J Med·2008
3-trial
Detecting nonpalpable recurrent breast cancer: the role of routine mammographic screening of transverse rectus abdominis myocutaneous flap reconstructions.
PMID 18539887·Radiology·2008
8-other
Coexistence of two rare sarcomas: primary leiomyosarcoma of bone and epithelioid hemangioendothelioma of the liver.
PMID 18382610·Sarcoma·2008
5-case
Case records of the Massachusetts General Hospital. Case 4-2008. A 33-year-old pregnant woman with swelling of the left breast and shortness of breath.
PMID 18234756·N Engl J Med·2008
5-case
CPA6, FMO2, LGI1, SIAT1 and TNC are differentially expressed in early- and late-stage oral squamous cell carcinoma--a pilot study.
PMID 18234543·Oral Oncol·2008
8-other
Open-label, uncontrolled, multicenter phase II study to evaluate the efficacy and toxicity of cetuximab as a single agent in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck who failed to respond to platinum-based therapy.
PMID 17538161·J Clin Oncol·2007
3-trial

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Request Appointment

This provider isn't set up for online booking yet. Once you submit, we'll reach out to their office to arrange secure delivery of your request.

Contact & Hours

Address
142 BRIGHTON LAKE RD
BRIGHTON, MI 48116

Quick Facts

NPI
1043547821
Entity Type
Individual
Gender
Female
Medicare
Accepted
Specialties
2
Locations
1
Years in Practice
21
Publications
20

Are you this provider?

Claim Your Profile